3-bromoquinoline-7-carboxylic acid;3-[4-[(2S)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;3-[4-[(2R)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;[(2R)-oxolan-2-yl]-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-azaspiro[2.5]octan-6-yl]methanone
C90H96BBrN6O14 — CID 158345184
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-bromoquinoline-7-carboxylic acid;3-[4-[(2S)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;3-[4-[(2R)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;[(2R)-oxolan-2-yl]-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-azaspiro[2.5]octan-6-yl]methanone
3-bromoquinoline-7-carboxylic acid;3-[4-[(2S)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;3-[4-[(2R)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;[(2R)-oxolan-2-yl]-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-azaspiro[2.5]octan-6-yl]methanone (PubChem CID 158345184) has the molecular formula C90H96BBrN6O14 and a molecular weight of 1576.50 g/mol. Its IUPAC name is 3-bromoquinoline-7-carboxylic acid;3-[4-[(2S)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;3-[4-[(2R)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;[(2R)-oxolan-2-yl]-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-azaspiro[2.5]octan-6-yl]methanone.
Molecular Properties
| Compound Name | 3-bromoquinoline-7-carboxylic acid;3-[4-[(2S)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;3-[4-[(2R)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;[(2R)-oxolan-2-yl]-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-azaspiro[2.5]octan-6-yl]methanone |
|---|---|
| PubChem CID | 158345184 |
| Molecular Formula | C90H96BBrN6O14 |
| Molecular Weight | 1576.50 g/mol |
| Exact Mass | 1574.63 |
| IUPAC Name | 3-bromoquinoline-7-carboxylic acid;3-[4-[(2S)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;3-[4-[(2R)-6-[(2R)-oxolane-2-carbonyl]-6-azaspiro[2.5]octan-2-yl]phenyl]quinoline-7-carboxylic acid;[(2R)-oxolan-2-yl]-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-azaspiro[2.5]octan-6-yl]methanone |
| SMILES | CC1(C)OB(c2ccc(C3CC34CCN(C(=O)[C@H]3CCCO3)CC4)cc2)OC1(C)C.O=C(O)c1ccc2cc(-c3ccc([C@@H]4CC45CCN(C(=O)[C@H]4CCCO4)CC5)cc3)cnc2c1.O=C(O)c1ccc2cc(-c3ccc([C@H]4CC45CCN(C(=O)[C@H]4CCCO4)CC5)cc3)cnc2c1.O=C(O)c1ccc2cc(Br)cnc2c1 |
| InChI | InChI=1S/2C28H28N2O4.C24H34BNO4.C10H6BrNO2/c2*31-26(25-2-1-13-34-25)30-11-9-28(10-12-30)16-23(28)19-5-3-18(4-6-19)22-14-20-7-8-21(27(32)33)15-24(20)29-17-22;1-22(2)23(3,4)30-25(29-22)18-9-7-17(8-10-18)19-16-24(19)11-13-26(14-12-24)21(27)20-6-5-15-28-20;11-8-3-6-1-2-7(10(13)14)4-9(6)12-5-8/h2*3-8,14-15,17,23,25H,1-2,9-13,16H2,(H,32,33);7-10,19-20H,5-6,11-16H2,1-4H3;1-5H,(H,13,14)/t23-,25+;23-,25-;19?,20-;/m011./s1 |
| InChIKey | GRQKHOLZJLHFKU-SBOJPOJOSA-N |
| XLogP | 15.71 |
| TPSA | 257.65 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 112 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1576.50 |
| LogP ≤ 5 | 15.71 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158345184 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.